Safety and performance of liver biopsies in liver transplant recipients

Clin Transplant. 2014 May;28(5):585-9. doi: 10.1111/ctr.12352. Epub 2014 Apr 21.

Abstract

Background: Liver biopsy in patients after liver transplantation (OLT) serves as a diagnostic tool to establish the cause of liver pathology. However, liver biopsy may cause life-threatening complications. Very limited information is available about complications and success rates of liver biopsies in patients after OLT. Our aim was to investigate biopsy-related complications and quality of specimen obtained by liver biopsy after OLT and to evaluate risks and benefits of this procedure.

Methods: Retrospective analysis of patients after OLT presenting for liver biopsy between January 2000 and October 2012. All patients were observed for 24 h after intervention. Twelve or more portal tracts were required for liver biopsy specimens to be considered as adequate.

Results: Of 703 liver biopsies were performed in 409 patients. Thirteen (1.9%) liver biopsies did not have an adequate number of portal tracts. Only 10 (1.4%) liver biopsies caused complications. Five patients suffered from pain, three patients developed post-procedural fever, and three patients had subcapsular/intercostal bleeding. One patient suffered from a vasovagal reaction. Pain was treated by analgesics; none of the patients required blood transfusion or surgery.

Conclusions: Liver biopsy is a safe and adequate diagnostic tool in patients after OLT.

Keywords: complication; liver biopsy; liver transplantation; quality.

MeSH terms

  • Adult
  • Biopsy
  • Female
  • Follow-Up Studies
  • Graft Rejection / diagnosis*
  • Graft Rejection / etiology
  • Humans
  • Liver Diseases / complications*
  • Liver Diseases / pathology
  • Liver Diseases / surgery
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Patient Safety
  • Postoperative Complications / diagnosis*
  • Postoperative Complications / etiology
  • Prognosis
  • Retrospective Studies
  • Transplant Recipients*